Characterization of chronic myeloid leukemia stem cells

Though tyrosine kinase inhibitors have redefined the care of chronic myeloid leukemia (CML), these agents have not proved curative, likely due to resistance of the leukemia stem cells (LSC). While a number of potential therapeutic targets have emerged in CML, their expression in the LSC remains larg...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gerber, Jonathan M., Qin, Lu, Kowalski, Jeanne, Smith, B. Douglas, Griffin, Constance A., Vala, Milada S., Collector, Michael I., Perkins, Brandy, Zahurak, Marianna, Matsui, William, Gocke, Christopher D., Sharkis, Saul J., Levitsky, Hyam I., Jones, Richard J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3010878/
https://ncbi.nlm.nih.gov/pubmed/21132730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.21915
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak